Annual Long Term Debt:
$2.91B+$205.60M(+7.61%)Summary
- As of today, REGN annual long term debt is $2.91 billion, with the most recent change of +$205.60 million (+7.61%) on December 31, 2024.
- During the last 3 years, REGN annual long term debt has risen by +$928.50 million (+46.89%).
- REGN annual long term debt is now at all-time high.
Performance
REGN Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Long Term Debt:
$2.71B+$400.00K(+0.01%)Summary
- As of today, REGN quarterly long term debt is $2.71 billion, with the most recent change of +$400.00 thousand (+0.01%) on September 30, 2025.
- Over the past year, REGN quarterly long term debt has increased by +$1.50 million (+0.06%).
- REGN quarterly long term debt is now -6.98% below its all-time high of $2.91 billion, reached on December 31, 2024.
Performance
REGN Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
REGN Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +7.6% | +0.1% |
| 3Y3 Years | +46.9% | +0.2% |
| 5Y5 Years | +307.4% | +0.4% |
REGN Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +46.9% | -7.0% | +0.2% |
| 5Y | 5-Year | at high | +307.4% | -7.0% | +36.7% |
| All-Time | All-Time | at high | >+9999.0% | -7.0% | >+9999.0% |
REGN Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $2.71B(+0.0%) |
| Jun 2025 | - | $2.71B(+0.0%) |
| Mar 2025 | - | $2.70B(-7.0%) |
| Dec 2024 | $2.91B(+7.6%) | $2.91B(+7.6%) |
| Sep 2024 | - | $2.70B(+0.0%) |
| Jun 2024 | - | $2.70B(+0.0%) |
| Mar 2024 | - | $2.70B(+0.0%) |
| Dec 2023 | $2.70B(+0.1%) | $2.70B(+0.0%) |
| Sep 2023 | - | $2.70B(+0.0%) |
| Jun 2023 | - | $2.70B(+0.0%) |
| Mar 2023 | - | $2.70B(+0.0%) |
| Dec 2022 | $2.70B(+36.4%) | $2.70B(+0.0%) |
| Sep 2022 | - | $2.70B(+0.0%) |
| Jun 2022 | - | $2.70B(+0.0%) |
| Mar 2022 | - | $2.70B(+36.4%) |
| Dec 2021 | $1.98B(-26.5%) | $1.98B(+0.0%) |
| Sep 2021 | - | $1.98B(+0.0%) |
| Jun 2021 | - | $1.98B(+0.0%) |
| Mar 2021 | - | $1.98B(-26.6%) |
| Dec 2020 | $2.70B(+277.6%) | $2.70B(+0.0%) |
| Sep 2020 | - | $2.69B(+276.4%) |
| Jun 2020 | - | $715.90M(+0.1%) |
| Mar 2020 | - | $715.20M(+0.2%) |
| Dec 2019 | $713.90M(+0.8%) | $713.90M(+0.2%) |
| Sep 2019 | - | $712.70M(+0.2%) |
| Jun 2019 | - | $711.30M(+0.2%) |
| Mar 2019 | - | $709.90M(+0.2%) |
| Dec 2018 | $708.50M(+0.7%) | $708.50M(+0.2%) |
| Sep 2018 | - | $707.20M(+0.2%) |
| Jun 2018 | - | $705.90M(+0.2%) |
| Mar 2018 | - | $704.64M(+0.2%) |
| Dec 2017 | $703.45M(+100.1%) | $703.45M(+0.2%) |
| Sep 2017 | - | $702.32M(+0.2%) |
| Jun 2017 | - | $701.17M(+0.1%) |
| Mar 2017 | - | $700.41M(+99.2%) |
| Dec 2016 | $351.57M(-3.1%) | $351.57M(-8.0%) |
| Sep 2016 | - | $382.23M(+5.7%) |
| Jun 2016 | - | $361.52M(-0.2%) |
| Mar 2016 | - | $362.23M(-0.2%) |
| Dec 2015 | $362.92M(-20.7%) | $362.92M(-8.1%) |
| Sep 2015 | - | $394.87M(+1.8%) |
| Jun 2015 | - | $388.05M(-17.9%) |
| Mar 2015 | - | $472.48M(+3.2%) |
| Dec 2014 | $457.71M(-9.3%) | $457.71M(-18.9%) |
| Sep 2014 | - | $564.06M(+9.1%) |
| Jun 2014 | - | $516.79M(-2.5%) |
| Mar 2014 | - | $530.05M(+5.0%) |
| Dec 2013 | $504.57M(+10.3%) | $504.57M(+4.8%) |
| Sep 2013 | - | $481.38M(+1.9%) |
| Jun 2013 | - | $472.51M(+2.4%) |
| Mar 2013 | - | $461.27M(+0.9%) |
| Dec 2012 | $457.26M(+4.6%) | $457.26M(+1.5%) |
| Sep 2012 | - | $450.46M(+1.2%) |
| Jun 2012 | - | $445.05M(+1.2%) |
| Mar 2012 | - | $439.74M(+0.6%) |
| Dec 2011 | $437.03M(+169.5%) | $437.03M(+174.0%) |
| Sep 2011 | - | $159.48M(+0.0%) |
| Jun 2011 | - | $159.46M(+0.1%) |
| Mar 2011 | - | $159.35M(-1.7%) |
| Dec 2010 | $162.18M(+48.8%) | $162.18M(+2.4%) |
| Sep 2010 | - | $158.38M(+0.7%) |
| Jun 2010 | - | $157.36M(+0.6%) |
| Mar 2010 | - | $156.46M(+43.5%) |
| Dec 2009 | $109.02M(>+9900.0%) | $109.02M(+74.2%) |
| Sep 2009 | - | $62.57M(-0.6%) |
| Jun 2009 | - | $62.92M(>+9900.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00 | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2007 | - | $200.00M(0.0%) |
| Jun 2007 | - | $200.00M(0.0%) |
| Mar 2007 | - | $200.00M(0.0%) |
| Dec 2006 | $200.00M(0.0%) | $200.00M(0.0%) |
| Sep 2006 | - | $200.00M(0.0%) |
| Jun 2006 | - | $200.00M(0.0%) |
| Mar 2006 | - | $200.00M(0.0%) |
| Dec 2005 | $200.00M(0.0%) | $200.00M(0.0%) |
| Sep 2005 | - | $200.00M(0.0%) |
| Jun 2005 | - | $200.00M(0.0%) |
| Mar 2005 | - | $200.00M(0.0%) |
| Dec 2004 | $200.00M(0.0%) | $200.00M(0.0%) |
| Sep 2004 | - | $200.00M(0.0%) |
| Jun 2004 | - | $200.00M(0.0%) |
| Mar 2004 | - | $200.00M(0.0%) |
| Dec 2003 | $200.00M(0.0%) | $200.00M(0.0%) |
| Sep 2003 | - | $200.00M(-2.5%) |
| Jun 2003 | - | $205.15M(+2.6%) |
| Mar 2003 | - | $200.00M(0.0%) |
| Dec 2002 | $200.00M(-0.1%) | $200.00M(0.0%) |
| Sep 2002 | - | $200.00M(0.0%) |
| Jun 2002 | - | $200.00M(-0.0%) |
| Mar 2002 | - | $200.05M(-0.0%) |
| Dec 2001 | $200.15M(+9573.8%) | $200.15M(>+9900.0%) |
| Sep 2001 | - | $1.65M(-5.9%) |
| Jun 2001 | - | $1.75M(-26.5%) |
| Mar 2001 | - | $2.38M(+14.9%) |
| Dec 2000 | $2.07M(-24.2%) | $2.07M(-5.0%) |
| Sep 2000 | - | $2.18M(-6.8%) |
| Jun 2000 | - | $2.34M(-7.3%) |
| Mar 2000 | - | $2.52M(-7.7%) |
| Dec 1999 | $2.73M(-10.9%) | $2.73M(+27.0%) |
| Sep 1999 | - | $2.15M(-12.6%) |
| Jun 1999 | - | $2.46M(-12.4%) |
| Mar 1999 | - | $2.81M(-8.4%) |
| Dec 1998 | $3.07M(-18.3%) | $3.07M(+14.0%) |
| Sep 1998 | - | $2.69M(-25.3%) |
| Jun 1998 | - | $3.60M(+3.7%) |
| Mar 1998 | - | $3.47M(-8.7%) |
| Dec 1997 | $3.75M(-27.1%) | $3.80M(-7.3%) |
| Sep 1997 | - | $4.10M(-2.4%) |
| Jun 1997 | - | $4.20M(-4.5%) |
| Mar 1997 | - | $4.40M(-13.7%) |
| Dec 1996 | $5.15M(-13.9%) | $5.10M(-1.9%) |
| Sep 1996 | - | $5.20M(+6.1%) |
| Jun 1996 | - | $4.90M(0.0%) |
| Mar 1996 | - | $4.90M(-18.3%) |
| Dec 1995 | $5.98M(-35.4%) | $6.00M(-14.3%) |
| Sep 1995 | - | $7.00M(-9.1%) |
| Jun 1995 | - | $7.70M(-10.5%) |
| Mar 1995 | - | $8.60M(-6.5%) |
| Dec 1994 | $9.25M(+56.5%) | $9.20M(+15.0%) |
| Sep 1994 | - | $8.00M(+11.1%) |
| Jun 1994 | - | $7.20M(-11.1%) |
| Mar 1994 | - | $8.10M(+37.3%) |
| Dec 1993 | $5.91M(+1.6%) | $5.90M(-4.8%) |
| Sep 1993 | - | $6.20M(-1.6%) |
| Jun 1993 | - | $6.30M(0.0%) |
| Mar 1993 | - | $6.30M(+8.6%) |
| Dec 1992 | $5.82M(+141.0%) | $5.80M(+11.5%) |
| Sep 1992 | - | $5.20M(+8.3%) |
| Jun 1992 | - | $4.80M(+17.1%) |
| Mar 1992 | - | $4.10M(+70.8%) |
| Dec 1991 | $2.41M | $2.40M(+242.9%) |
| Sep 1991 | - | $700.00K(+133.3%) |
| Jun 1991 | - | $300.00K |
FAQ
- What is Regeneron Pharmaceuticals, Inc. annual long term debt?
- What is the all-time high annual long term debt for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. annual long term debt year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. quarterly long term debt?
- What is the all-time high quarterly long term debt for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. quarterly long term debt year-on-year change?
What is Regeneron Pharmaceuticals, Inc. annual long term debt?
The current annual long term debt of REGN is $2.91B
What is the all-time high annual long term debt for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high annual long term debt is $2.91B
What is Regeneron Pharmaceuticals, Inc. annual long term debt year-on-year change?
Over the past year, REGN annual long term debt has changed by +$205.60M (+7.61%)
What is Regeneron Pharmaceuticals, Inc. quarterly long term debt?
The current quarterly long term debt of REGN is $2.71B
What is the all-time high quarterly long term debt for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high quarterly long term debt is $2.91B
What is Regeneron Pharmaceuticals, Inc. quarterly long term debt year-on-year change?
Over the past year, REGN quarterly long term debt has changed by +$1.50M (+0.06%)